Minami Hironobu | 神戸大学医学研究科腫瘍内科学

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
Twelve Novel Single Nucleotide Polymorphisms in the CES2 Gene Encoding Human Carboxylesterase 2 (hCE-2)
Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
日本人におけるヒトSLC29A1の新規遺伝子多型の同定
Genetic Variation and Haplotype Structure of the ABC Transporter Gene ABCG2 in a Japanese Population
Genetic Variations and Haplotypes of UGT1A4 in a Japanese Population
Genetic Polymorphisms of UGT1A6 in a Japanese Population
Genetic Variations of the AHR Gene Encoding Aryl Hydrocarbon Receptor in a Japanese Population
Three Novel Single Nucleotide Polymorphisms in UGT1A9
Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
Novel Genetic Polymorphisms in the NR3C1 (Glucocorticoid receptor) Gene in a Japanese Population
Twenty-six Novel Single Nucleotide Polymorphisms and their Frequencies of the NR113 (CAR) Gene in a Japanese Population
Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
Three novel single nucleotide polymorphisms in UGT1A10
Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases
Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors
Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice
Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients
Extragonadal germ cell tumors in Japan
Treatable Subsets in Cancer of Unknown Primary Origin
Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
Population pharmacokinetic and pharmacodynamic analysis for time courses of docetaxel-induced neutropenia in Japanese cancer patients
Effect of axitinib (AG-013736) on fatigue, thyroid-stimulating hormone, and biomarkers : A phase I study in Japanese patients
Prognostic Factors for Short-term Survival in Patients with Stage IV Non-small Cell Lung Cancer
Pharmacokinetic Study of Carboplatin Given on a 5-Day Intravenous Schedule
Therapeutic Drug Monitoring in 21-Day Oral Etoposide Treatment for Lung Cancer
Therapeutic Drug Monitoring of Etoposide in a 14-Day Infusion for Non-small-cell Lung Cancer
Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3-Hour Infusion of Paclitaxel
Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer
Occult Thymic Carcinoma Presenting as Malignant Cardiac Tamponade
Review of primary unknown cancer : cases referred to the National Cancer Center Hospital East
Phase I dose escalation and pharmacokinetic study of oral enzastaurin (LY317615) in advanced solid tumors
Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck

もっと見る

スポンサーリンク